Maeda T, Eto M, Nishimura Y, Nomoto K, Kong Y Y, Nomoto K
Department of Immunology, Kyushu University, Fukuoka, Japan.
Immunology. 1993 Jan;78(1):113-21.
It has previously been reported that a single i.p. injection of 200 mg/kg cyclophosphamide (CP) 2 days after priming with 10(8) donor spleen cells (SC) leads to donor-specific skin allograft tolerance in H-2 compatible, multiminor antigen incompatible murine strain combinations. It is speculated that the i.v. injection of donor cells may result in synchronized proliferation of donor-reactive host T cells and subsequently administered CP may specifically destroy these proliferating T cells in the periphery. Although this unique action of CP is considered to be a principal mechanism in this method, direct evidence has not yet been obtained. In the present article, this in vivo destructive effect of CP is clearly demonstrated by assessing detailed kinetics of host-derived blastoid T cells and donor (Mls-1a)-reactive V beta 6+ T cells in the model system of C3H mice rendered tolerant to AKR. Frequencies of the blastoid cells and V beta 6+ cells, which increased as a result of AKR priming, decreased rapidly with the administration of CP. C3H mice, which received AKR SC alone, also exhibited partial deletion of V beta 6+ T cells, but both tempo and magnitude of decrease in the frequency of V beta 6+ cells were quite different from those of the C3H mice given AKR SC and CP, which showed more rapid and profound elimination of V beta 6+ T cells. In accordance with these kinetic studies, in vitro proliferative response to Mls-1a antigens was greatly impaired in mice treated with SC and CP, whereas a low but appreciable response was detected in mice given SC alone.(ABSTRACT TRUNCATED AT 250 WORDS)
先前有报道称,在用10(8)个供体脾细胞(SC)进行致敏2天后,单次腹腔注射200 mg/kg环磷酰胺(CP)可使H-2相容、多微小抗原不相容的小鼠品系组合产生供体特异性皮肤同种异体移植耐受。据推测,静脉注射供体细胞可能导致供体反应性宿主T细胞同步增殖,随后给予的CP可能在外周特异性破坏这些增殖的T细胞。尽管CP的这种独特作用被认为是该方法的主要机制,但尚未获得直接证据。在本文中,通过评估对AKR产生耐受的C3H小鼠模型系统中宿主来源的母细胞样T细胞和供体(Mls-1a)反应性Vβ6 + T细胞的详细动力学,清楚地证明了CP的这种体内破坏作用。由于AKR致敏而增加的母细胞样细胞和Vβ6 +细胞的频率,随着CP的给药而迅速下降。仅接受AKR SC的C3H小鼠也表现出Vβ6 + T细胞的部分缺失,但Vβ6 +细胞频率下降的速度和幅度与给予AKR SC和CP的C3H小鼠有很大不同,后者显示Vβ6 + T细胞的消除更快且更彻底。根据这些动力学研究,用SC和CP处理的小鼠对Mls-1a抗原的体外增殖反应大大受损,而仅给予SC的小鼠则检测到低但明显的反应。(摘要截短于250字)